Last reviewed · How we verify
NCT07398274: ÖrSBID
The Örebro Severe Traumatic Brain Injury Registry
trial in Severe Traumatic Brain Injury in 200 participants. Not yet recruiting.
8 February 2028
Quick facts
| Lead sponsor | András Zoltán Buki |
|---|---|
| Status | Not yet recruiting |
| Study type | OBSERVATIONAL |
| Enrollment | 200 |
| Start date | 8 February 2026 |
| Primary completion | 8 February 2028 |
| Estimated completion | 15 February 2028 |
| Sites | 1 location across Sweden |
Conditions studied
- Severe Traumatic Brain Injury — all drugs for Severe Traumatic Brain Injury →
- Severe Brain Injury — all drugs for Severe Brain Injury →
- Ischemic Stroke — all drugs for Ischemic Stroke →
- Intracerebral Hemorrhage — all drugs for Intracerebral Hemorrhage →
Sponsor
András Zoltán Buki
Who can join
18 and older, any sex, with Severe Traumatic Brain Injury or Severe Brain Injury. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Traumatic brain injury and other severe brain injuries requiring neurointensive care are associated with high mortality, long-term disability and substantial societal burden. Despite advances in critical care, outcomes after severe brain injury remain difficult to predict and secondary brain injury plays a major role in determining prognosis. The Örebro Severe Brain Injury Database (ÖrSBID) is a prospective observational registry that aims to systematically collect detailed clinical, physiological, imaging and biological data from adult patients with severe brain injury requiring care at the neurointesive care unit or neurointermediate care unit at Örebro University Hospital. The purpose of the registry is to enable deep phenotyping of severe brain injury, improve understanding of secondary injury mechanisms, support outcome prediction and provide a platform for longitudinal follow-up and future research. No experimental interventions are performed as part of the study.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07398274
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Severe Traumatic Brain Injury
Currently open trials in the same condition.
- NCT06560372 — Incidence, Characteristics and Evolution of Cerebral Vasospasm With Clinical Impact in Moderate to Severe Traumatic Brai · NA · recruiting
- NCT05889650 — External Lumbar Drainage to Reduce ICP in Severe TBI: a Phase 1 Clinical Trial · NA · recruiting
- NCT05566431 — Benchmark Evidence Led by Latin America: Trial of Intracranial Pressure - Pediatrics · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07398274 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by András Zoltán Buki
- Last refreshed: 9 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07398274.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing